Novita Pharmaceuticals, Inc.
Clinical trials sponsored by Novita Pharmaceuticals, Inc., explained in plain language.
-
New drug combo shows promise against tough cancers
Disease control OngoingThis study tests an experimental drug called NP-G2-044, given alone or with an immunotherapy (anti-PD-1), in people with advanced or metastatic solid tumors that have not responded to other treatments. The main goals are to find the safest dose and see if the drug can shrink tumo…
Phase: PHASE1, PHASE2 • Sponsor: Novita Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo aims to outsmart Platinum-Resistant ovarian cancer
Disease control OngoingThis study tests a new drug called NP-G2-044 (Prilukae) combined with standard chemotherapy (PLD) in people with ovarian cancer that no longer responds to platinum-based treatments. About 380 participants will receive either the combo or PLD alone to see if the combination improv…
Phase: PHASE2, PHASE3 • Sponsor: Novita Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC